Daidzein Inhibits Non-small Cell Lung Cancer Growth by Pyroptosis

Fanfan Zeng,Yu Zhang,Ting Luo,Chengman Wang,Denggang Fu,Xin Wang
DOI: https://doi.org/10.2174/0113816128330530240918073721
IF: 3.31
2024-12-04
Current Pharmaceutical Design
Abstract:CONCLUSION: In summary, this study demonstrated that daidzein inhibits NSCLC growth by inducing pyroptosis. Key pathway modulators ASC, CASP1, and IL-1β were identified as primary targets of daidzein. These findings offer insights into the molecular mechanisms underlying the anti-NSCLC effects of daidzein and could offer dietary recommendations for managing NSCLC.
pharmacology & pharmacy
What problem does this paper attempt to address?